Urinary human papillomavirus DNA as an indicator of gynaecological infection in young women in Schistosoma and HIV endemic South Africa

BackgroundGlobally, Africa has the highest HIV, cervical cancer and schistosomiasis prevalence. Female Genital Schistosomiasis (FGS) is hypothesized to be associated with HIV and cervical atypia. Young women aged 15 and above, constituting almost 3 million of the South African population, have limit...

Full description

Saved in:
Bibliographic Details
Main Authors: P. Pillay, H. N. Galappaththi-Arachchige, M. Taylor, B. Roald, E. F. Kjetland
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Global Women's Health
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fgwh.2024.1436064/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832590860588417024
author P. Pillay
H. N. Galappaththi-Arachchige
M. Taylor
B. Roald
B. Roald
E. F. Kjetland
E. F. Kjetland
author_facet P. Pillay
H. N. Galappaththi-Arachchige
M. Taylor
B. Roald
B. Roald
E. F. Kjetland
E. F. Kjetland
author_sort P. Pillay
collection DOAJ
description BackgroundGlobally, Africa has the highest HIV, cervical cancer and schistosomiasis prevalence. Female Genital Schistosomiasis (FGS) is hypothesized to be associated with HIV and cervical atypia. Young women aged 15 and above, constituting almost 3 million of the South African population, have limited health care access and are at risk for this triad of diseases. Urinary HPV DNA analysis is a non-invasive sampling method that can assist in evaluating risk among this population. This study compared the analysis of HPV DNA in urine and cervico-vaginal lavage (CVL) samples to cytology Pap smear, Schistosoma microscopy and HIV results.MethodsIn this cross-sectional study, 235 young women aged 16 years and older from rural high schools in KwaZulu-Natal participated. HPV DNA analysis was done in urine and CVL samples. Pap smears were analysed for squamous cell atypia and urine microscopy was used for the identification of Schistosoma ova.ResultsUrinary schistosomiasis was reported in 49 (20.9%) and HIV detected in 49 (20.4%). Urinary and CVL HPV DNA was found in 147 (62.6%) and 177 (75.3%) respectively. Any atypia was detected cytologically among 173 (73.6%). The following associations were found using the Pearson Chi-Square and a Likelihood Ratio test: (a) between HIV positive status and urinary HPV DNA positive cases on both the urine (X2 = 5.007; p-value = 0.025) and (X2 = 4.264; p-value = 0.039) and between HIV positive status and CVL HPV DNA tests respectively (X2 = 5.165; p-value = 0.023) and (X2 = 4.321; p-value = 0.015), and (b) among urine HPV DNA and the CVL HPV DNA tests, where (X2 = 52.966; p-value = 0.001) and (X2 = 50.716; p-value = 0.001). Urine HPV DNA showed a sensitivity of 75.7% and specificity of 77.6% relative to the CVL HPV DNA. There was no statistical association between urinary schistosomiasis and HPV or with any atypia.ConclusionUrine has the potential of being optimized as an alternative and possibly more acceptable sample for HPV detection among young adolescent populations at risk in comparison to CVL samples. An integrated targeted intervention incorporating Schistosoma in addition to HPV and HIV testing needs consideration among young women in this age group from endemic areas.
format Article
id doaj-art-086840917f5849078c8a4b65bd68f73e
institution Kabale University
issn 2673-5059
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Global Women's Health
spelling doaj-art-086840917f5849078c8a4b65bd68f73e2025-01-23T06:56:08ZengFrontiers Media S.A.Frontiers in Global Women's Health2673-50592025-01-01510.3389/fgwh.2024.14360641436064Urinary human papillomavirus DNA as an indicator of gynaecological infection in young women in Schistosoma and HIV endemic South AfricaP. Pillay0H. N. Galappaththi-Arachchige1M. Taylor2B. Roald3B. Roald4E. F. Kjetland5E. F. Kjetland6Department of Biomedical and Clinical Technology, Faculty of Health Sciences, Durban University of Technology, KwaZulu-Natal, South AfricaFaculty of Medicine, University of Oslo, Oslo, NorwayDiscipline of Public Health Medicine, University of KwaZulu-Natal, Durban, South AfricaFaculty of Medicine, University of Oslo, Oslo, NorwayDepartment of Pathology, Oslo University Hospital, Oslo, NorwayDiscipline of Public Health Medicine, University of KwaZulu-Natal, Durban, South AfricaNorwegian Centre for Imported and Tropical Diseases, Department of Infectious Diseases, Oslo University Hospital, Oslo, NorwayBackgroundGlobally, Africa has the highest HIV, cervical cancer and schistosomiasis prevalence. Female Genital Schistosomiasis (FGS) is hypothesized to be associated with HIV and cervical atypia. Young women aged 15 and above, constituting almost 3 million of the South African population, have limited health care access and are at risk for this triad of diseases. Urinary HPV DNA analysis is a non-invasive sampling method that can assist in evaluating risk among this population. This study compared the analysis of HPV DNA in urine and cervico-vaginal lavage (CVL) samples to cytology Pap smear, Schistosoma microscopy and HIV results.MethodsIn this cross-sectional study, 235 young women aged 16 years and older from rural high schools in KwaZulu-Natal participated. HPV DNA analysis was done in urine and CVL samples. Pap smears were analysed for squamous cell atypia and urine microscopy was used for the identification of Schistosoma ova.ResultsUrinary schistosomiasis was reported in 49 (20.9%) and HIV detected in 49 (20.4%). Urinary and CVL HPV DNA was found in 147 (62.6%) and 177 (75.3%) respectively. Any atypia was detected cytologically among 173 (73.6%). The following associations were found using the Pearson Chi-Square and a Likelihood Ratio test: (a) between HIV positive status and urinary HPV DNA positive cases on both the urine (X2 = 5.007; p-value = 0.025) and (X2 = 4.264; p-value = 0.039) and between HIV positive status and CVL HPV DNA tests respectively (X2 = 5.165; p-value = 0.023) and (X2 = 4.321; p-value = 0.015), and (b) among urine HPV DNA and the CVL HPV DNA tests, where (X2 = 52.966; p-value = 0.001) and (X2 = 50.716; p-value = 0.001). Urine HPV DNA showed a sensitivity of 75.7% and specificity of 77.6% relative to the CVL HPV DNA. There was no statistical association between urinary schistosomiasis and HPV or with any atypia.ConclusionUrine has the potential of being optimized as an alternative and possibly more acceptable sample for HPV detection among young adolescent populations at risk in comparison to CVL samples. An integrated targeted intervention incorporating Schistosoma in addition to HPV and HIV testing needs consideration among young women in this age group from endemic areas.https://www.frontiersin.org/articles/10.3389/fgwh.2024.1436064/fullurinehuman papillomavirusDNAcervico-vaginal lavagefemale genital schistosomiasis
spellingShingle P. Pillay
H. N. Galappaththi-Arachchige
M. Taylor
B. Roald
B. Roald
E. F. Kjetland
E. F. Kjetland
Urinary human papillomavirus DNA as an indicator of gynaecological infection in young women in Schistosoma and HIV endemic South Africa
Frontiers in Global Women's Health
urine
human papillomavirus
DNA
cervico-vaginal lavage
female genital schistosomiasis
title Urinary human papillomavirus DNA as an indicator of gynaecological infection in young women in Schistosoma and HIV endemic South Africa
title_full Urinary human papillomavirus DNA as an indicator of gynaecological infection in young women in Schistosoma and HIV endemic South Africa
title_fullStr Urinary human papillomavirus DNA as an indicator of gynaecological infection in young women in Schistosoma and HIV endemic South Africa
title_full_unstemmed Urinary human papillomavirus DNA as an indicator of gynaecological infection in young women in Schistosoma and HIV endemic South Africa
title_short Urinary human papillomavirus DNA as an indicator of gynaecological infection in young women in Schistosoma and HIV endemic South Africa
title_sort urinary human papillomavirus dna as an indicator of gynaecological infection in young women in schistosoma and hiv endemic south africa
topic urine
human papillomavirus
DNA
cervico-vaginal lavage
female genital schistosomiasis
url https://www.frontiersin.org/articles/10.3389/fgwh.2024.1436064/full
work_keys_str_mv AT ppillay urinaryhumanpapillomavirusdnaasanindicatorofgynaecologicalinfectioninyoungwomeninschistosomaandhivendemicsouthafrica
AT hngalappaththiarachchige urinaryhumanpapillomavirusdnaasanindicatorofgynaecologicalinfectioninyoungwomeninschistosomaandhivendemicsouthafrica
AT mtaylor urinaryhumanpapillomavirusdnaasanindicatorofgynaecologicalinfectioninyoungwomeninschistosomaandhivendemicsouthafrica
AT broald urinaryhumanpapillomavirusdnaasanindicatorofgynaecologicalinfectioninyoungwomeninschistosomaandhivendemicsouthafrica
AT broald urinaryhumanpapillomavirusdnaasanindicatorofgynaecologicalinfectioninyoungwomeninschistosomaandhivendemicsouthafrica
AT efkjetland urinaryhumanpapillomavirusdnaasanindicatorofgynaecologicalinfectioninyoungwomeninschistosomaandhivendemicsouthafrica
AT efkjetland urinaryhumanpapillomavirusdnaasanindicatorofgynaecologicalinfectioninyoungwomeninschistosomaandhivendemicsouthafrica